Emerging, noninvasive surrogate markers of atherosclerosis

Samir N. Patel; Venkataraman Rajaram; Sanjay Pandya; Benjamin M. Fiedler; Charlotte J. Bai; Rachel Neems; Matt Feinstein; Marshall Goldin; Steven B. Feinstein

doi:10.1007/s11883-004-0117-3

Emerging, noninvasive surrogate markers of atherosclerosis

Samir N. Patel, Venkataraman Rajaram, Sanjay Pandya, Benjamin M. Fiedler, Charlotte J. Bai, Rachel Neems, Matt Feinstein, Marshall Goldin, Steven B. Feinstein^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Review article › peer-review

23 Scopus citations

Abstract

Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.

Original language	English (US)
Pages (from-to)	60-68
Number of pages	9
Journal	Current atherosclerosis reports
Volume	6
Issue number	1
DOIs	https://doi.org/10.1007/s11883-004-0117-3
State	Published - Jan 2004

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11883-004-0117-3

Cite this

@article{ab183515a4db4e53b1d36e84040aae4c,

title = "Emerging, noninvasive surrogate markers of atherosclerosis",

abstract = "Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.",

author = "Patel, {Samir N.} and Venkataraman Rajaram and Sanjay Pandya and Fiedler, {Benjamin M.} and Bai, {Charlotte J.} and Rachel Neems and Matt Feinstein and Marshall Goldin and Feinstein, {Steven B.}",

year = "2004",

month = jan,

doi = "10.1007/s11883-004-0117-3",

language = "English (US)",

volume = "6",

pages = "60--68",

journal = "Current atherosclerosis reports",

issn = "1523-3804",

publisher = "Current Medicine Group",

number = "1",

}

TY - JOUR

T1 - Emerging, noninvasive surrogate markers of atherosclerosis

AU - Patel, Samir N.

AU - Rajaram, Venkataraman

AU - Pandya, Sanjay

AU - Fiedler, Benjamin M.

AU - Bai, Charlotte J.

AU - Neems, Rachel

AU - Feinstein, Matt

AU - Goldin, Marshall

AU - Feinstein, Steven B.

PY - 2004/1

Y1 - 2004/1

N2 - Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.

AB - Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=3142628403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142628403&partnerID=8YFLogxK

U2 - 10.1007/s11883-004-0117-3

DO - 10.1007/s11883-004-0117-3

M3 - Review article

C2 - 14662109

AN - SCOPUS:3142628403

SN - 1523-3804

VL - 6

SP - 60

EP - 68

JO - Current atherosclerosis reports

JF - Current atherosclerosis reports

IS - 1

ER -

Emerging, noninvasive surrogate markers of atherosclerosis

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this